|
It was reported a turbo-ject® single lumen power-injectable picc placed on (b)(6) 2018 was found fractured where the line joins the hub.The device was being used to deliver long term antibiotics.The device was removed on (b)(6) 2018 and a second picc line, reported on medwatch 1820334-2018-03538, was place via wire exchange on (b)(6) 2018.As reported, the patient required suspension of treatment while the device was removed and replaced.This report is related to mdr's: 1820334-2018-03538 and 1820334-2018-03537 as they involve the same patient.
|
|
Blank fields on this form indicate the information is unchanged, unknown or unavailable.Corrected data: this field was inadvertently reported as yes under the initial mdr.The initial reporter submitted a report to their national competent authority tga not fda.Device evaluation the complaint device was not returned.So, a physical inspection of the complaint device was not performed.However, pictures of the complaint device were sent which aided the investigation.Additionally, a document based investigation evaluation was performed.Investigation a document-based investigation reviewed the following: documentation, instructions for use, quality control specifications, complaint history and device history records.A review of relevant manufacturing documents was conducted.It was concluded that the device aspect in question was visually/functionally inspected by quality control and no related gaps in production or processing controls were noted.A review of the device history record of the finished product shows no nonconforming events.A complaint history search revealed one other reported complaint (separated) for this lot number.Since this complaint is related to the complaint issue, appropriate product and quality managers have been alerted.Conclusion based on the information provided, the photos provided, and the results of our investigation, the root cause has been identified as cause traced to device design: design inadequate for purpose.Risk assessment identified that appropriate measures have been initiated to address this failure mode.The appropriate personnel were notified.We will continue to monitor for similar complaints.This report is required by the fda under 21 cfr part 803.This report is based on unconfirmed information submitted by others.Neither the submission of this report nor any statement made in it is intended to be an admission that any cook device is defective or malfunctioned; that a death or serious injury occurred; or that any cook device caused or contributed to; or is likely to cause or contribute to a death or serious injury if a malfunction occurred.
|